Biomedical Translation Fund (BTF)

Gives organizations investment through authorized private segment support administrators to create and commercialise biomedical revelations in Australia.

At a minimum, at the time of the first investment, you must be an eligible company that is, or will be, developing and commercialising biomedical discoveries and have

  • a majority of your employees and assets inside Australia, or will use the whole of the initial investment within Australia
  • an average annual revenue over the previous two years below $25 million per year.

Other eligibility requirements apply.

The rest of this grant's information is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
New User Registration
*Required field